These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31567700)

  • 1. Eradicating hepatitis C virus: The APRN's role.
    Pozza R; McCoy-Hill C; Hall K; Hefner A; Wilgers K; Tapelband J; Masroor M; Hassanein T
    Nurse Pract; 2019 Nov; 44(11):16-27. PubMed ID: 31567700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Ward JW; Hinman AR
    Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Approaches Toward Eliminating Hepatitis C Virus in Rhode Island.
    Murphy M; Howe K; Marak T; Bertrand T; Maynard M; Ndoye CD; Joseph R; Fingerut J; Chan PA
    R I Med J (2013); 2020 Jun; 103(5):22-25. PubMed ID: 32481775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    Gvinjilia L; Nasrullah M; Sergeenko D; Tsertsvadze T; Kamkamidze G; Butsashvili M; Gamkrelidze A; Imnadze P; Kvaratskhelia V; Chkhartishvili N; Sharvadze L; Drobeniuc J; Hagan L; Ward JW; Morgan J; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1132-1135. PubMed ID: 27764081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is global elimination of HCV realistic?
    Calvaruso V; Petta S; Craxì A
    Liver Int; 2018 Feb; 38 Suppl 1():40-46. PubMed ID: 29427499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing Interventions on Medication Adherence During Hepatitis C Treatment: Application of Self-Regulation Model.
    Williams SA
    Gastroenterol Nurs; 2018; 41(6):525-531. PubMed ID: 30489409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global burden of hepatitis C: considerations for healthcare providers in the United States.
    Averhoff FM; Glass N; Holtzman D
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S10-5. PubMed ID: 22715208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely J; Dore GJ
    Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
    Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thanetkongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Sochoo S; Pongsuwan N; Poovorawan K; Tangkijvanich P; Poovorawan Y
    PLoS One; 2018; 13(4):e0196301. PubMed ID: 29689073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eradication of HCV.
    De Nicola S; Colombo M
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):63-75. PubMed ID: 26446686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 30 Years on the Road to Hepatitis C Elimination.
    Thomas DL
    J Infect Dis; 2020 Nov; 222(Suppl 9):S739-S740. PubMed ID: 33245352
    [No Abstract]   [Full Text] [Related]  

  • 15. Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis G; Razavi H; Hatzakis A
    J Gastroenterol Hepatol; 2017 Feb; 32(2):466-472. PubMed ID: 27403912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C is for communication.
    Copley L
    Nurs Stand; 2004 Nov 3-9; 19(8):19. PubMed ID: 15552464
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral hepatitis elimination should receive more attention from Iranian nurses.
    Bayatpoor ME; Karimi-Sari H; Alavian SM
    Res Nurs Health; 2018 Feb; 41(1):9-10. PubMed ID: 29266371
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    Nasrullah M; Sergeenko D; Gvinjilia L; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Alkhazashvili M; Shadaker S; Ward JW; Morgan J; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):773-776. PubMed ID: 28749925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
    Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.
    Grebely J; Matthews GV; Lloyd AR; Dore GJ
    Clin Infect Dis; 2013 Oct; 57(7):1014-20. PubMed ID: 23728143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.